Clinical Trial Update: Safety Study of Galantamine in Tic Disorders [Phase 4]

View source ↗

Summary

Phase 4 safety study of galantamine in tic disorders has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Motor Tic Disorder
• Tourette Syndrome
• Vocal Tic Disorder

Drugs mentioned

• Galantamine (galantamine)

Snippet

Sponsor: Parkinson's Disease and Movement Disorders Center | Conditions: Tourette's Syndrome, Motor Tic Disorder | Phase 4 | Status: TERMINATED